Product Program year 2021 Source: CMS Open Payments

Propel

Device Otolaryngology (Ear, Nose, Throat)

Open in the dashboard

General payments

$912,101

9,378 payments

Research payments

$297,881

44 payments

Through program year 2021, $912,101 in general payments and $297,881 in research payments were reported against Propel (Otolaryngology (Ear, Nose, Throat)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2021 General $279,814 2,468
2021 Research $297,881 44
2020 General $95,074 1,644
2019 General $537,213 5,266

Breakdown

Who paid General payments · program years 2019–2021
  1. Intersect ENT, Inc. $912,101 9,378 payments
Top recipients General payments · program year 2021
  1. Ian Humphreys Otolaryngology · Seattle, WA $27,000 10% · 2 payments
  2. Boris Karanfilov Otolaryngology · Dublin, OH $14,016 5% · 10 payments
  3. Anil Gungor Otolaryngology · Corpus Christi, TX $13,500 5% · 1 payment
  4. James Kallman Plastic Surgery within the Head & Neck · Anchorage, AK $12,119 4% · 4 payments
  5. Abib Agbetoba Otolaryngology · Bellaire, TX $6,886 2% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Otolaryngology $223,053 83% · 943 practitioners
  2. Plastic Surgery within the Head & Neck Otolaryngology $17,798 7% · 34 practitioners
  3. Otolaryngology/Facial Plastic Surgery Otolaryngology $9,119 3% · 78 practitioners
  4. Facial Plastic Surgery Otolaryngology $4,893 2% · 38 practitioners
  5. Physician Assistant $4,317 2% · 89 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $45,847 16% · 151 recipients
  2. California $42,502 15% · 118 recipients
  3. Washington $33,034 12% · 32 recipients
  4. Ohio $17,617 6% · 45 recipients
  5. Louisiana $13,920 5% · 13 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

9,378 general · 44 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record